The supervisory board of personal care ingredient distributor Brenntag has appointed Thomas Reisten as chief financial officer, effective 1 April.
Reisten will be responsible for accounting, controlling, investor relations, legal, shared services, tax, treasury, and insurance; his contract runs until 31 March 2028.
He succeeds Dr Kristin Neumann, who will not be extending her contract, which ends on 31 March, for personal reasons, as communicated last October.
Reisten, born in 1972, was most recently chief financial officer and member of the management board at Vantage Towers, a leading tower company in Europe.
Richard Ridinger, chairman of the supervisory board of Brenntag SE said: “With Thomas Reisten, we have gained a very internationally positioned and versatile top manager.
“During his many years of working for globally active, listed companies in the telecommunications technology and infrastructure sector, he has acquired extensive operational, financial and capital market expertise.
“Coupled with his strong commercial and strategic focus, he brings all the skills needed to implement Brenntag’s strategy and transformation and to prepare the company for future opportunities and further growth.”
